key: cord-0939805-jvm8rm3k authors: Park, H.; Wang, T. D.; Wattanasin, N.; Castro, V. M.; Gainer, V.; Goryachev, S.; Murphy, S. title: The Digital Analytic Patient Reviewer (DAPR) for COVID-19 Data Mart Validation date: 2021-06-01 journal: nan DOI: 10.1101/2021.05.30.21257945 sha: 62a4546ef0c861cae8f85540b30caccdd078e115 doc_id: 939805 cord_uid: jvm8rm3k Objective: To provide high-quality data for COVID-19 research, we validated COVID-19 clinical indicators and 22 associated computed phenotypes, which were derived by machine learning algorithms, in the Mass General Brigham (MGB) COVID-19 Data Mart. Materials and Methods: Fifteen reviewers performed a manual chart review for 150 COVID-19 positive patients in the data mart. To support rapid chart review for a wide range of target data, we offered the Digital Analytic Patient Reviewer (DAPR). DAPR is a web-based chart review tool that integrates patient notes and provides note search functionalities and a patient-specific summary view linked with relevant notes. Within DAPR, we developed a COVID-19 validation task-oriented view and information extraction logic, enabled fast access to data, and considered privacy and security issues. Results: The concepts for COVID-19 positive cohort, COVID-19 index date, COVID-19 related admission, and the admission date were shown to have high values in all evaluation metrics. For phenotypes, the overall specificities, PPVs, and NPVs were high. However, sensitivities were relatively low. Based on these results, we removed 3 phenotypes from our data mart. In the survey about using the tool, participants expressed positive attitudes towards using DAPR for chart review. They assessed the validation was easy and DAPR helped find relevant information. Some validation difficulties were also discussed. Discussion and Conclusion: DAPR's patient summary view accelerated the validation process. We are in the process of automating the workflow to use DAPR for chart reviews. Moreover, we will extend its use case to other domains. Background When the COVID-19 pandemic arrived in the US [1], there was a growing demand for COVID-19-related data in the research community. Providing accurate and fluent data in a timely manner is essential to conquering this unprecedented disease. Mass General Brigham (MGB) Research admission date, and 22 machine learning phenotypes (Y/N) considered to be associated with COVID-19 (Table 1) When searching, it highlights the term in preview search results and in the actual note. The QPID . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint was originally designed for clinical use in radiology department. However, due to its useful features for patient chart review, it had often been used for validation by other clinical and research groups. We reimplemented the service as a research tool for our COVID-19 data validation task. First, we created a COVID-19 validation task-oriented summary view (Figure 1 ). We selected COVID-19-relevant information and past medical history that would help the validation and reorganized the summary list. We placed COVID -19-relevant concepts on the top row and past medical history to the bottom. In the 'COVID -19' row, we sectioned the category into COVID -19 status, risk factors, severity, and management. For each section, we listed frequently used concepts in clinical settings. In the bottom row, we reused part of the summary list existed in the former version, since the list have been useful for various chart reviews. Furthermore, we integrated the 22 target phenotypes into this category as the 'PHENOTYPES' section. We added 127 new summary items and developed information extraction logic to find relevant notes and highlight key information. We built the logic in QQL and specified patterns using extended keywords and code information as well as date and note type constraints. Second, for faster access, we pre-loaded and pre-cached patient data before starting the validation. Currently, DAPR integrates all note data from multiple clinical data resources. Getting patient data takes considerable amount of time and can be a burden to the source systems during working hours. Furthermore, the summary view displays 196 items. Combined with default rules, more than 250 NLP rules needed to be computed to ensure speedy access. Therefore, we pre-loaded all the target patient data during nighttime and computed the NLP rules. The precomputed results are cached in a table so that all the refined information can be loaded immediately. Third, to protect patient privacy and security, we added a module to check . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. an 'allowed patient list' for individual validators. We restrict data access to patients assigned to that validator. In addition, we set DAPR up as accessible only by verified users, through our MGB network or VPN. Finally, we built a database and an administrator dashboard to manage users, projects, and audit. Fifteen reviewers validated COVID-19 indicators and 22 phenotypes of 150 patients. One experienced reviewer in our group validated 100 patients, and the other fourteen volunteers from the working group validated 55 patients. We divided the 55 patients into 11 groups, 5 patients each. Each validator was assigned at least one data set. The reviewers who were willing to validate more data were given another data set. Twenty seven patients were cross validated. The authors participated as adjudicators for a final decision of any discrepancies between two validators. We provided data in an encrypted data sheet file. Only the assigned patients were listed in a data file. Data was displayed in one row per patient. We added a row for the validation result and a row for comments below each patient. We also included a data dictionary that described the definition of the data columns, temporal extraction logic, and reasons for inclusion. Reviewers had freedom to use Epic (i.e., MGB EHR system) and (or) DAPR to validate the assigned data. We required volunteers to receive IRB approval and to take a training about the purpose of the validation and using DAPR for it. Then we assigned patient set(s) and registered them into DAPR. They could access only the assigned patients on DAPR. We also sent a welcome email with instructions and the encrypted patient data table file. A password to open the data file was sent by a separate email. The result was received back by email. All the emails were . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint transferred via secure emails. When the validation is completed, we asked them to participate a survey about the validation experience and the DAPR tool. We validated 150 COVID-19 positive patients' data in the MGB COVID-19 Data Mart. As the validation was a voluntary work, not all reviewers completed all assigned labels. For COVID-19 patient cohort and index date, 102 patients were validated. However, all the other data types were validated for all 150 patients. Total 3,804 labels were reviewed and 697 of them were validated twice by different reviewers. We evaluated the performance of the selected data types in the COVID-19 Data Mart ( Table 2 ). The COVID-19 positive cohort was highly accurate (95.10% of positive predictive value (PPV)). Table. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint seemed to have many different words for same thing, the easier ones seemed to always use the same terminology." P7 added a detail of the same context, "I, being lack of clinical training, it took more time connecting diseases, signs, tests, medication etc. together to make a decision." P5, who noted is an experienced reviewer in the survey comment, also had difficulties in certain phenotypes due to lack of specialty in that domain: "Those particular phenotypes were harder to discern because there seemed to be many ways they could be listed or noted in the patient's chart. It was harder for me, since I'm (obviously) not a cardiologist, to be able to clearly separate these diagnoses from others." In addition, the extraction coverage being different from its phenotype definition or redundant phenotype items returning different list arose confusion to reviewers. These made them spend extra efforts to understand how the phenotype is identified. Although P2 expressed "I feel that the current summary table puts the sensitivity into a higher priority compared with specificity. This is reasonable and maybe the best choice." Many pointed out that the returned note list do not exactly support the (non-)existence of the phenotypes: "[The prebuilt logics] might not have captured the whole situation for a phenotype" (P7), "the definition and the query algorithm seem to be different" (P8), and "[Summary items return] more evidence and related diseases in that category" (P2). Moreover, P1 mentioned about the redundant summary view items, "Sometimes the past medical history did not seem to match the phenotypes. For example, there are two valve diseases, one in past medical history section and the other in phonotype section which were not always consistent" Consequently, participants had questions about the phenotype definitions: "The definition/scope of some of the phenotype was ambiguous/wide" (P3), "not clear definition of a phenotype to me" (p7). They shared that they had to go through multiple notes (P9: "Had to go through multiple . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. Participants showed satisfaction for being involved in this validation work: "Thanks for letting me in this project" (P7) and "delighted to be involved" (P10). Nine participants showed willingness to participate in the future validation again (Figure 2(g) ). One of the biggest problems of validating COVID-19 data was that large number of COVID-19 patients do not have rich data in our system. Many of them were transferred patients or were previously healthy. This situation created the need for note review to discover patient history not existing in coded data fields. DAPR provided a way to use NLP in an automated way to extract buried patient information. In the survey, a participant noted using DAPR was more useful than just searching notes via Epic due to its extensive search ability. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. In addition to reviving the QPID service as DAPR, we made efforts to repurpose it to support COVID-19 validation. We created a custom COVID-19 validation summary view and developed information extraction logics through MGB RISC NLP pipeline. We also made a module to facilitate testing and uploading the NLP rules efficiently. Moreover, we considered practical and proper use of the tool. To enable faster access, to protect patient privacy and security, and to manage administrative issues, we built formal processes and additional system modules such as precaching, checking allow list, administration tool, etc. Based on the survey results, the main barriers that created difficulty for some phenotypes were is not the only domain that could benefit from DAPR. Many data in the summary view are commonly used indicators in patient review that are useful. There have been already requests to use DAPR from multiple groups. Several validation projects are underway using DAPR. On the other hand, currently, some workflow steps remain manual and limit wide use. We are working to automate and operationalize it to meet growing demands. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint In this study, we used an NLP-based chart review tool, DAPR, for COVID-19 associated data validation and contributed building a reliable COVID-19 research data mart. We transitioned DAPR from a clinical tool to a research tool. We designed a COVID-19 relevant patient summary view and built new information extraction rules. We enabled faster loading by preloading and precaching the patients. We added components to safeguard patient privacy, to harden information security, and to provide auditing capabilities to adhere to IRB governance. We also designed a new workflow to use DAPR for validation. The results show how the use of NLP technique can help overcome unusual challenges brought by COVID-19. Although the reviewers had various clinical backgrounds and they had to find information for wide domains of target data mostly from notes, all of them could complete the tasks in a short amount of time. However, in some phenotypes, the outcomes extracted by NLP rules were unable to capture all possible situations. It required users to make additional efforts to search for clues using their knowledge. It remains as a limitation of using an NLP tool for validation. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. Figure 1. DAPR screen DAPR is a patient specific chart review tool. If users enter a patient identifier on the top search box, it displays patient name, MGB site name, and demographic information on the top, all note list categorized by note types in the left panel, and a summary view generated by prebuilt NLP rules on the right. Every medical concept in the summary view is linked to an information extraction rule that retrieves a note list which contains relevant information. When users mouseover a summary item, it pops up a window that shows its internal extraction logic and notes retrieved. As seen in the popup window titled 'NSAIDs', NLP rules used in DAPR include extensive relevant keyword information and patterns. They greatly reduce search efforts. If users mouseover one of the note list, it drills down to the note content with highlighted keyword information (see the other popup on top of NSAIDs popup). Users can also search for notes and access the contents by user keywords or a regular expression in the left panel's search box. This figure uses a fictitious patient data for demonstration purpose. * This image is loading a demo patient . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 1, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint (e) Different level of difficulties of target phenotypes (n=10) 80% (8) 20% (2) some phenotypes were more difficult No particular phenotype was difficult . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint (g) Willingness to participate in the future validation (n=10) 90% (9) 10% (1) yes no . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21257945 doi: medRxiv preprint New COVID-19 Tools for Researchers Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection COVID-19 severity in asthma patients: a multi-center matched cohort study Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19 Electronic Health Record Documentation of Psychiatric Predicting COVID-19 mortality with electronic medical records SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19," medRxiv : the preprint server for health sciences ICD-10-CM COVID-19 coding and reporting guidelines LOINC COVID-19 Prerelease Terms